Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
48M
-
Shares change
-
-212K
-
Total reported value, excl. options
-
$386M
-
Value change
-
+$34M
-
Put/Call ratio
-
0.61
-
Number of buys
-
49
-
Number of sells
-
-43
-
Price
-
$8.04
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2019
137 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q1 2019.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48M shares
of 159M outstanding shares and own 30.21% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (8.2M shares), MILLENNIUM MANAGEMENT LLC (4.91M shares), BlackRock Inc. (4.44M shares), BRIDGER MANAGEMENT, LLC (4M shares), VANGUARD GROUP INC (3.38M shares), STATE STREET CORP (3.28M shares), FMR LLC (2.4M shares), Opaleye Management Inc. (1.37M shares), CREDIT AGRICOLE S A (1.31M shares), and Point72 Asset Management, L.P. (1.28M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.